HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

13-cis-Retinoic acid: inhibition of bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.

Abstract
Transitional cell carcinoma was induced in the bladders of male Fischer rats by 12 oral doses of the carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine. Feeding of 13-cis-retinoic acid after completion of carcinogen treatment diminished the number and severity of cancers and other proliferative lesions of the bladder.
AuthorsC J Grubbs, R C Moon, R A Squire, G M Farrow, S F Stinson, D G Goodman, C C Brown, M B Sporn
JournalScience (New York, N.Y.) (Science) Vol. 198 Issue 4318 Pg. 743-4 (Nov 18 1977) ISSN: 0036-8075 [Print] United States
PMID910158 (Publication Type: Journal Article)
Chemical References
  • Nitrosamines
  • Vitamin A
  • Butylhydroxybutylnitrosamine
  • Tretinoin
Topics
  • Animals
  • Butylhydroxybutylnitrosamine
  • Carcinoma, Transitional Cell (chemically induced, drug therapy, prevention & control)
  • Male
  • Neoplasms, Experimental (chemically induced, drug therapy, prevention & control)
  • Nitrosamines
  • Rats
  • Rats, Inbred F344
  • Tretinoin (therapeutic use)
  • Urinary Bladder Neoplasms (chemically induced, drug therapy, prevention & control)
  • Vitamin A (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: